-
Opioids Market Set to Surge to $6.1 Billion by 2030 at a 3.2% CAGR
31 Jan 2025 19:51 GMT
…
- Endo Pharmaceuticals Inc.
- Teva Pharmaceuticals
- Pfizer, Inc.
Challenges and …
-
Senators Reintroduce FDA Modernization Act 3.0 To Wind Down Costly Animal Tests In Drug Development
31 Jan 2025 19:05 GMT
… for Public Policy, SPCA International, Teva Pharmaceuticals, PETA, the Rare and Undiagnosed …
-
Peptide Therapeutics Market Poised for 9.1% CAGR Growth
31 Jan 2025 14:34 GMT
… Inc.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceuticals Industries Ltd.
• Lonza Inc.
• Sanofi …
-
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals
08 Jan 2025 17:30 GMT
… Settlement Agreement (Agreement) with Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. (collectively Teva …
-
Camylofin Market Set to Witness Significant Growth by 2024-2031: Mylan, Teva Pharmaceuticals, Zydus Cadila, Merck
17 Dec 2024 09:03 GMT
…
◘ Gedeon Richter
◘ Hetero Labs
◘ Mylan
◘ Teva Pharmaceuticals
◘ Zydus Cadila
This Report includes …
-
Heparin Market Grows Steadily with Rising Demand for Anticoagulants | CAGR 6.6%
30 Jan 2025 21:07 GMT
… KGaA,
• Viatris Inc.,
• Pfizer Inc.,
• Teva Pharmaceuticals,
• Leo Pharma A/S …
-
Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain
30 Jan 2025 18:00 GMT
… , Centrexion Therapeutics, Braeburn Pharmaceuticals, Regeneron, Teva Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Vertanical …
-
Biosimilars Market Industry Trends and Global Forecasts to 2035, Featuring Amgen, BIOCAD, Biocon, Celltrion, Coherus BioSciences, Eli Lilly, Fresenius Kabi, Pfizer, Sandoz and Teva Pharmaceuticals - ResearchAndMarkets.com
10 Dec 2024 14:58 GMT
…
Intas Pharmaceuticals
Pfizer
Sandoz
STADA
Teva Pharmaceuticals
Key Topics Covered:
INTRODUCTION
Overview … ;s Laboratories
Celltrion
Intas Pharmaceuticals
Teva Pharmaceuticals
REGULATORY LANDSCAPE
COST PRICE ANALYSIS …
-
Opioid Market to rise at a 3.4% CAGR from 2024 to 2034 to reach a Valuation of US$ 63,472.6 million | Fact.MR
30 Jan 2025 17:15 GMT
… Inc.; Allergen Plc; Merck KGaA; Teva Pharmaceuticals; Mylan N.V.
Competitive Landscape …
About
© 1995-2025